Milojkovic, D., Cross, N. C. P., Ali, S., Byrne, J., Campbell, G., Dignan, F. L., Drummond, M., Huntly, B., Marshall, S., McMullin, M. F., Neelakantan, P., Raghavan, M., Sivakumaran, M., Tighe, J., Wandroo, F., Willis, F., Glen, F., Fildes, L., Collington, S. J., Ryan, J., Clark, R. E., & Mead, A. J. (2021). real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study. British journal of haematology, 192, 62–74. http://access.bl.uk/ark:/81055/vdc_100117919009.0x00005f